Arcadia Biosciences, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Arcadia Biosciences announces its 2026 Annual Meeting of Stockholders, proposing director elections, equity incentive plans, and a reverse stock split to maintain Nasdaq compliance.
NASDAQ
Arcadia Biosciences, Inc. announced its 2025 Annual Meeting of Stockholders to be held virtually on December 19, 2025, to vote on director elections, executive compensation, and auditor ratification.
NASDAQ
DEFA14A: Arcadia Biosciences Sets Date for 2024 Annual Meeting, Proposes Equity Incentive Plan Amendment
Arcadia Biosciences has scheduled its annual stockholder meeting for June 25, 2024, and is seeking votes on director elections, auditor ratification, an equity incentive plan amendment, and executive compensation.
NASDAQ
Arcadia Biosciences is holding its 2024 Annual Meeting virtually on June 25, 2024, to vote on director elections, auditor ratification, an equity incentive plan amendment, and executive compensation.